Growing technological complexity continues to drive firms to interact with the external innovation eironment to achieve firm success. However, industries’ complexities and the business model concept’s underlying ontology have limited research on modeling the key factors that enable this interface. In this study, results of an empirical analysis of a unique dataset of 102 biopharmaceutical companies broadly support the EC-LQO five-factor framework as a useful tool to guide business model innovation for highly knowledge-intensive eironments.
For knowledge-intensive industries, a need remains to increase clarity on the dynamics through which business model innovation occurs. Progress has been limited owing to complexities in these industries and to the underlying ontology of the business model concept itself. Through a conceptual methodology, our findings expose impediments to current business model theory and propose economic evolutionary theory as a useful alternative lens through which to address these limitations. This research contributes to the literature by broadening the traditional scope of the economic evolutionary view as relevant for business model innovation research and by offering a corresponding framework for future research.
The negotiation challenge
(2018)
Inspired by https://thenegotiationchallenge.org/what-is-tnc/, a leading annual student negotiation competition, this book includes 16 ready-to-use, competition-tested negotiation roleplay simulations with thorough instructional debriefs that suggest both optimal strategies and discuss potential results. The main objective of this book is to help potential participants, their negotiation professors and coaches prepare for and prevail in negotiation competitions. It is also well suited for negotiation instructors looking for new and proven teaching material or for anyone interested in practicing and improving their negotiation skills.
Business model innovation opportunities for the biopharmaceutical industry: a systematic review
(2016)
Research on business model innovation for the biopharmaceutical industry continues to be an area of high global interest due to the combination of industry innovation challenges and global macroeconomic pressures. Through the use of a systematic literature review the purpose of this research is to explore the universe of academic literature published from 1976 to 2013 that has addressed business model relevant factors and dynamics in the biopharmaceutical industry and inductively mine this literature for insights into the opportunities for business model innovation. After identifying and reviewing 305 relevant publications, 12 categories were developed and key dynamics discussed. The author finds that opportunities for business model innovation lie in five key areas, External Orientation, Learning Capabilities, Cluster Participation, Qualified Business Management Team and Organization Controls. This research provides not only insight into opportunities for business model innovation specific to this industry but also can be used independently as a valuable reference tool for similar research._x000D_ Keywords: Biotechnology, business model, innovation, management, pharmaceutical_x000D_